Vitamin Shoppe, Inc. (NYSE: VSI) today announced that the public offering of 6,236,320 shares of its common stock has priced at $23.50 per share. All of the shares of common stock are being sold by certain stockholders of Vitamin Shoppe. The underwriters have a 30-day option to purchase up to an additional 935,448 shares from the selling stockholders.
The selling stockholders will receive all of the proceeds from this offering, and Vitamin Shoppe will not receive any proceeds from the sale of shares in this offering. Irving Place Capital Partners II, L.P. is the principal stockholder of Vitamin Shoppe and is a selling stockholder in this offering. In addition, members of management of Vitamin Shoppe and certain of its other equity holders are also selling stockholders in the offering.
J.P.Morgan, BofA Merrill Lynch and Barclays Capital are acting as joint book-running managers for the offering. Stifel Nicolaus, Baird and Piper Jaffray are the co-managers of the offering.
Ultra-processed foods linked to liver disease and insulin resistance in obese children